TSRI Scientists Stabilize HIV Structure, Design Potential AIDS Vaccine Candidates The findings represent a 'big accomplishment' in biomedical engineering and design.
TSRI Scientists Find New Cancer Drug Target in Dual-Function Protein The study reveals that the protein GlyRS is actually a double-agent.
TSRI Scientists Reveal Single-Neuron Gene Landscape of the Human BrainNewly identified neuronal diversity provides insights into brain function and disease.
New TSRI Method Opens Door to Development of Many New Medicines The findings reveal human proteins are better drug targets that previously thought.
Discovered: A New Protein Crucial to Normal ForgettingStudy reveals possible strategy for treating memory disorders such as Alzheimer’s disease.
Scientists Create Compound that Erases Disease-Causing RNA DefectsNew drug candidate shows potential in treating spinocerebellar ataxia, a currently incurable disease.
New HIV-Mimicking Particles Could Advance AIDS VaccineThe HIV-like nanoparticles trigger an immune response.
Skaggs Family Gives $2 Million for New TSRI Graduate Program Endowment The gift will support exceptional students in TSRI’s highly ranked graduate program.
Harnessing Nature’s Vast Array of Venoms for Drug Discovery TSRI chemists have developed a method to isolate and analyze venoms, opening the door to new, more potent therapeutics.
Scripps Florida Scientists Show Commonly Prescribed Painkiller Slows Cancer Growth The new study in animal models focused on the effects of celecoxib (Pfizer’s Celebrex®).
Discovered: Mechanism that Turns Mutant Cells into Aggressive CancersThe research also suggests a possible way to kill these types of tumors.
Researchers Show Experience Plays Powerful Role in Early Brain Circuit DevelopmentThe findings also have implications for drug development.
TSRI Celebrates 24th CommencementThirty-six students received PhDs and an honorary degree was awarded to renowned molecular biologist and biochemist Phillip A. Sharp.